4th Quarter - Report — THE DUBERSTEIN GROUP INC. for PFIZER INC. (2021)

Firm

THE DUBERSTEIN GROUP INC.

Client

PFIZER INC.

Income

$60,000

Expenses

—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

General Outreach / Introductions

Lobbyist	Covered position, as disclosed
ELIZABETH KELLEY	—

Contacted: Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Taxation/Internal Revenue Code TAX

Excise Tax / CICP

Lobbyist	Covered position, as disclosed
ELIZABETH KELLEY	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS)

Health Issues HCR

General Outreach / Introductions Drug Pricing Outreach regarding pharmaceutical supply chain issues MADE Act (H.R.3927 / S.2082)

Lobbyist	Covered position, as disclosed
BRIAN GRIFFIN	—
BENJAMIN R HOWARD	—
KATHERINE WINKLER KEATING	—
ELIZABETH KELLEY	—
DAVID J SCHIAPPA	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); SENATE; Office of Science & Technology Policy (OSTP)

Bills named: S. 2082 (117th), H.R. 3927 (117th)

Budget/Appropriations BUD

Biosimilar utilization

Lobbyist	Covered position, as disclosed
DAVID J SCHIAPPA	—

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.